14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -3.187 20 days ( 5.00 % )
Last Price $2.28 1.33 %
High/ Low $2.24 - $2.40 11.49%
Chg 7 Days 2.70 % $2.22 $2.28
Chg 30 Days -16.18 % $2.72 $2.28
Chg 12 mos 131.83 % $0.98 $2.28
Trend - 3 mos 31.13 % Width: 116.33 %
Trend - 12 mos 53.83 % Width: 201.45 %
Pred. range - 3 mos $2.46 - $5.32 7.84 % - 133.28 %
Pred. range - 12 mos $1.93 - $5.80 -15.56 % - 154.54 %
Short MA avg 3 mos Buy May 02, 2024 - 3 days
Long MA avg 3 mos Sell Apr 08, 2024 - 21 days
Short/Long MA avg 3 mos Sell Apr 10, 2024 - 19 days
Short MA avg 12 mos Buy May 02, 2024 - 3 days
Long MA avg 12 mos Buy Jan 25, 2024 - 71 days
Short/Long MA avg 12 mos Buy Jan 31, 2024 - 67 days
Pivot Short Sell Mar 27, 2024 - 28 days
Bollinger Buy Feb 02, 2024 - 65 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About BeyondSpring Inc

BeyondSpring BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combinati... BYSI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT